MX2019010143A - Bifidobacterium longum capaz de modular beneficiosamente la respuesta inmune contra una infeccion respiratoria por virus. - Google Patents
Bifidobacterium longum capaz de modular beneficiosamente la respuesta inmune contra una infeccion respiratoria por virus.Info
- Publication number
- MX2019010143A MX2019010143A MX2019010143A MX2019010143A MX2019010143A MX 2019010143 A MX2019010143 A MX 2019010143A MX 2019010143 A MX2019010143 A MX 2019010143A MX 2019010143 A MX2019010143 A MX 2019010143A MX 2019010143 A MX2019010143 A MX 2019010143A
- Authority
- MX
- Mexico
- Prior art keywords
- bifidobacterium longum
- immune response
- virus infection
- respiratory virus
- modulate immune
- Prior art date
Links
- 241001608472 Bifidobacterium longum Species 0.000 title abstract 3
- 229940009291 bifidobacterium longum Drugs 0.000 title abstract 3
- 230000009385 viral infection Effects 0.000 title abstract 2
- 230000028993 immune response Effects 0.000 title 1
- 230000000241 respiratory effect Effects 0.000 title 1
- 208000035143 Bacterial infection Diseases 0.000 abstract 1
- 241000709661 Enterovirus Species 0.000 abstract 1
- 206010062106 Respiratory tract infection viral Diseases 0.000 abstract 1
- 208000036142 Viral infection Diseases 0.000 abstract 1
- 208000022362 bacterial infectious disease Diseases 0.000 abstract 1
- 206010022000 influenza Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/314—Foods, ingredients or supplements having a functional effect on health having an effect on lung or respiratory system
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/324—Foods, ingredients or supplements having a functional effect on health having an effect on the immune system
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/332—Promoters of weight control and weight loss
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/533—Longum
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Otolaryngology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Una cepa aislada de Bifidobacterium Iongum NCIMB 42020 es útil para el tratamiento de infecciones virales, especialmente infecciones respiratorias virales tales como influenza, rinovirus y RSV. Bifidobacterium Iongum NCIMB 42020 también es útil para eliminar infecciones bacterianas secundarias.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP17158567 | 2017-02-28 | ||
EP17158564 | 2017-02-28 | ||
PCT/EP2018/054914 WO2018158306A1 (en) | 2017-02-28 | 2018-02-28 | Bifidobacterium longum able to beneficially modulate immune response to respiratory virus infection |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2019010143A true MX2019010143A (es) | 2019-10-02 |
Family
ID=61521511
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2019010143A MX2019010143A (es) | 2017-02-28 | 2018-02-28 | Bifidobacterium longum capaz de modular beneficiosamente la respuesta inmune contra una infeccion respiratoria por virus. |
Country Status (13)
Country | Link |
---|---|
US (1) | US11529381B2 (es) |
EP (1) | EP3532603B1 (es) |
JP (1) | JP7055814B2 (es) |
KR (1) | KR20190123267A (es) |
CN (1) | CN110352237B (es) |
AU (1) | AU2018227020B2 (es) |
BR (1) | BR112019017940A2 (es) |
CA (1) | CA3054099A1 (es) |
DK (1) | DK3532603T3 (es) |
ES (1) | ES2834950T3 (es) |
MX (1) | MX2019010143A (es) |
RU (1) | RU2768030C2 (es) |
WO (1) | WO2018158306A1 (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MY157133A (en) * | 2008-05-27 | 2016-05-13 | Spawnt Private S À R L | Silicon containing halogenide, method for producing the same, and use of the same |
WO2018209308A1 (en) * | 2017-05-12 | 2018-11-15 | The Regents Of The University Of California | Treating and detecting dysbiosis |
JP2019167327A (ja) * | 2018-03-26 | 2019-10-03 | 森永乳業株式会社 | ビフィドバクテリウム属細菌を有効成分とする、iii型インターフェロン産生促進用組成物 |
AR119031A1 (es) * | 2019-05-28 | 2021-11-17 | Aybar Ecotechnologies Corp | Formulaciones farmacéuticas antibacterianas de amplio espectro que comprenden lisozima y métodos de utilización de la misma |
WO2021180973A1 (en) * | 2020-03-13 | 2021-09-16 | Precisionbiotics Group Limited | Bifidobacterium longum |
CN111529703B (zh) * | 2020-06-17 | 2023-09-15 | 湖南循天然营养有限公司 | 一种组合物及其制备方法与在制备免疫佐剂中的应用 |
WO2023120547A1 (ja) * | 2021-12-22 | 2023-06-29 | 株式会社明治 | 二次性感染症の予防又は発症リスクを低減するための組成物 |
Family Cites Families (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1598457A (en) | 1977-03-22 | 1981-09-23 | Glaxo Lab Ltd | Process for the preparation of a fraction containing peptidoglycan material from streptomyces griseus |
DE3024318A1 (de) | 1980-06-27 | 1982-01-28 | Chemisches Laboratorium Dr. Karl Richter GmbH, 1000 Berlin | Kosmetische mittel |
RU2151606C1 (ru) | 1998-07-09 | 2000-06-27 | Российский государственный медицинский университет | Штамм бактерий bifidobacterium longum z4 для приготовления бактерийных препаратов, нормализующих микрофлору при нарушениях микробиоценоза влагалища |
PE20030284A1 (es) * | 2001-07-26 | 2003-05-01 | Alimentary Health Ltd | Cepas de bifidobacterium |
RU2216588C1 (ru) | 2002-05-17 | 2003-11-20 | Государственное учреждение Московский научно-исследовательский институт эпидемиологии и микробиологии им. Г.Н.Габричевского | Штамм bifidobacterium longum я2, используемый для получения кисломолочных, ферментированных и неферментированных пищевых продуктов, заквасок, гигиенических и косметических средств, биологически активных добавок и бактерийных препаратов |
CN1183960C (zh) | 2003-02-27 | 2005-01-12 | 四川大学 | 双歧杆菌细胞壁蛋白在制药中的应用 |
JP2007169200A (ja) | 2005-12-21 | 2007-07-05 | Morinaga Milk Ind Co Ltd | インフルエンザ感染予防のための医薬及び飲食品 |
RU2314341C1 (ru) | 2006-07-13 | 2008-01-10 | Федеральное Государственное учреждение науки "Московский научно-исследовательский институт эпидемиологии и микробиологии им. Г.Н. Габричевского" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека | Штамм bifidobacterium longum гв-15, используемый для получения кисломолочных, ферментированных и неферментированных пищевых продуктов, заквасок, гигиенических и косметических средств, биологически активных добавок и бактерийных препаратов |
US20080118473A1 (en) | 2006-11-01 | 2008-05-22 | The Procter & Gamble Company | Methods of treating a respiratory condition comprising probiotic treatment |
KR20100016012A (ko) | 2007-03-28 | 2010-02-12 | 앨러멘터리 헬스 리미티드 | 프로바이오틱 비피도박테리움 스트레인 |
GB2460781B (en) * | 2007-03-28 | 2012-01-25 | Alimentary Health Ltd | Probiotic bifidobacterium strains |
CN101835806B (zh) | 2007-05-04 | 2012-11-07 | 营养健康有限公司 | 外泌多糖 |
CA2713525A1 (en) * | 2008-02-06 | 2009-08-13 | The Procter & Gamble Company | Compositions methods and kits for enhancing immune response to a respiratory condition |
EP2254541A1 (en) * | 2008-03-17 | 2010-12-01 | The Procter & Gamble Company | User-customizable dosing system |
FR2937547B1 (fr) | 2008-10-28 | 2012-11-09 | Oreal | Utilisation d'un lysat de microorganisme pour le traitement des peaux grasses |
EP2289527B1 (en) | 2009-08-25 | 2018-02-21 | Nestec S.A. | Bifidobacterium longum and functional GI disorders |
FI20096058A0 (fi) | 2009-10-13 | 2009-10-13 | Valio Oy | Koostumuksia ja niihin liittyviä menetelmiä ja käyttöjä |
MX2012005449A (es) * | 2009-11-11 | 2012-09-07 | Iams Company | Una cepa de bifidobacterium. |
CA2779418C (en) * | 2009-11-11 | 2018-03-20 | Alimentary Health Limited | Probiotic bifidobacterium strain |
EP2611484A4 (en) | 2010-09-02 | 2016-03-09 | Sipnose Ltd | DEVICE FOR NASAL ADMINISTRATION |
EP2455092A1 (en) | 2010-11-11 | 2012-05-23 | Nestec S.A. | Non-replicating probiotic micro-organisms protect against upper respiratory tract infections |
CN102321187B (zh) | 2011-08-15 | 2013-04-17 | 内蒙古双奇药业股份有限公司 | 一种从长双歧杆菌nq-1501中提取完整肽聚糖的方法 |
US20130165470A1 (en) * | 2011-12-21 | 2013-06-27 | The Procter & Gamble Company | Methods for Detecting and Treating Rhinovirus Infection |
CA2923982A1 (en) | 2013-08-12 | 2015-02-19 | Mansel Griffiths | Antiviral methods and compositions comprising probiotic bacterial molecules |
WO2015140299A1 (en) | 2014-03-20 | 2015-09-24 | Universiteit Antwerpen | Oronasopharyngeal probiotics |
JP6941562B2 (ja) | 2014-07-16 | 2021-09-29 | デポファルマ ソチエタ ペル アツィオニDepofarma S.P.A. | 免疫調節作用を有するプロピオニバクテリウム・アクネスおよびプロピオニバクテリウム・グラヌローサムの細胞壁画分 |
DK3250216T3 (da) * | 2015-01-27 | 2024-01-29 | Dupont Nutrition Biosci Aps | Immunmodulatorisk sammensætning, som omfatter bifidobakterier |
RU2017133256A (ru) | 2015-03-09 | 2019-04-09 | Биоиммунизер Сагл | Композиция против старения, содержащая комбинацию антиоксидантных агентов в сочетании с бифидобактериями и выделенными из пробиотиков клеточными стенками |
US20180280453A1 (en) * | 2015-08-27 | 2018-10-04 | Alimentary Health Limited | Use of bifidobacterium longum and an exopolysaccharide produced thereby |
JP6637725B2 (ja) | 2015-10-28 | 2020-01-29 | ビオフェルミン製薬株式会社 | ウイルス感染症の予防及び/又は治療剤 |
IT201600091033A1 (it) | 2016-09-08 | 2018-03-08 | Bioimmunizer Sagl | Ceppi di batteri probiotici appartenenti al genere Bifidobacterium e loro estratti di cellule probiotiche (ECP) aventi proprietà immunostimolanti. |
CN110392734A (zh) | 2017-02-28 | 2019-10-29 | 营养健康有限公司 | 可以有益地调节针对呼吸道病毒感染的免疫应答的长双歧杆菌 |
JPWO2018168449A1 (ja) | 2017-03-17 | 2020-01-16 | 国立大学法人東北大学 | ペプチドグリカン認識タンパク質産生促進用組成物 |
-
2018
- 2018-02-28 MX MX2019010143A patent/MX2019010143A/es unknown
- 2018-02-28 DK DK18707915.7T patent/DK3532603T3/da active
- 2018-02-28 JP JP2019546824A patent/JP7055814B2/ja active Active
- 2018-02-28 US US16/489,141 patent/US11529381B2/en active Active
- 2018-02-28 CN CN201880014451.7A patent/CN110352237B/zh active Active
- 2018-02-28 WO PCT/EP2018/054914 patent/WO2018158306A1/en unknown
- 2018-02-28 BR BR112019017940A patent/BR112019017940A2/pt unknown
- 2018-02-28 RU RU2019128539A patent/RU2768030C2/ru active
- 2018-02-28 KR KR1020197024317A patent/KR20190123267A/ko not_active Application Discontinuation
- 2018-02-28 AU AU2018227020A patent/AU2018227020B2/en active Active
- 2018-02-28 EP EP18707915.7A patent/EP3532603B1/en active Active
- 2018-02-28 ES ES18707915T patent/ES2834950T3/es active Active
- 2018-02-28 CA CA3054099A patent/CA3054099A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
BR112019017940A2 (pt) | 2020-05-19 |
CN110352237B (zh) | 2023-01-10 |
WO2018158306A1 (en) | 2018-09-07 |
RU2768030C2 (ru) | 2022-03-23 |
RU2019128539A3 (es) | 2021-07-01 |
WO2018158306A8 (en) | 2019-04-25 |
JP2020508672A (ja) | 2020-03-26 |
EP3532603B1 (en) | 2020-09-09 |
US20200000859A1 (en) | 2020-01-02 |
JP7055814B2 (ja) | 2022-04-18 |
DK3532603T3 (da) | 2020-12-07 |
CA3054099A1 (en) | 2018-09-07 |
EP3532603A1 (en) | 2019-09-04 |
ES2834950T3 (es) | 2021-06-21 |
KR20190123267A (ko) | 2019-10-31 |
AU2018227020A1 (en) | 2019-08-29 |
RU2019128539A (ru) | 2021-03-30 |
US11529381B2 (en) | 2022-12-20 |
CN110352237A (zh) | 2019-10-18 |
AU2018227020B2 (en) | 2023-08-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2019010143A (es) | Bifidobacterium longum capaz de modular beneficiosamente la respuesta inmune contra una infeccion respiratoria por virus. | |
MX2018008413A (es) | Virus oncolitico modificado. | |
EA201990566A1 (ru) | Композиции, содержащие бактериальные штаммы | |
WO2015153889A3 (en) | Materials and methods for the treatment of latent viral infection | |
MX2016014807A (es) | Singenes de alfa(1,2)fucosiltransferasa para su utilizacion en la produccion de oligosacaridos fucosilados. | |
MX2022005253A (es) | Anticuerpos neutralizantes de poliomavirus. | |
MX2019007613A (es) | Terapia de combinacion con compuestos ?-lactamicos sustituidos con amidina e inhibidores de ?-lactamasa para infecciones con cepas bacterianas resistentes a antibioticos. | |
MA40765A (fr) | Méthodes et compositions d'induction d'une immunité protectrice contre l'infection par le virus de l'immunodéficience humaine | |
EP3474861A4 (en) | COMPOUNDS COMPRISING HMOS FOR THE PREVENTION AND / OR TREATMENT OF VIRAL AND / OR BACTERIAL INFECTIONS. | |
WO2019106578A3 (en) | Polyomavirus neutralizing antibodies | |
PH12018550110A1 (en) | Novel probiotic bacterial strain of lactobacillus plantarum and compositions and uses thereof in the treatment of inflammation | |
WO2018231992A3 (en) | METHODS OF USING LACTOBACILLUS PLANTARUM STRAINS TO PROTECT ANIMALS AGAINST PATHOGENIC BACTERIAL INFECTION | |
MX2021012984A (es) | Anticuerpos y metodos para el tratamiento de la infeccion por influenza a. | |
MX2022016066A (es) | Nuevo inhibidor de proteina-cinasa-cinasa activada por mitogeno (mek) para el tratamiento de infecciones virales y bacterianas. | |
WO2016205641A3 (en) | Respiratory syncytial virus having cleavage-resistant g protein and related materials and methods | |
WO2023004415A3 (en) | Sars-cov-2 vaccine using bacterial spores expressing antigenic fragments | |
EA202190876A1 (ru) | Композиции, содержащие бактериальные штаммы | |
EP3757207A4 (en) | Bifidobacterium lungum rapo strain for alleviation, prevention, or treatment of rheumatoid arthritis and composition comprising same | |
PH12019550183A1 (en) | Treatment of infant colic | |
WO2018237010A3 (en) | VACCINE COMPOSITIONS AGAINST STREPTOCOCCUS AND THEIR METHODS OF USE | |
MX2017007969A (es) | Bacterias de acido lactico y su uso para el tratamiento de mastitis. | |
WO2017053525A3 (en) | Influenza vaccine and therapy | |
MX2021012604A (es) | Nuevo inhibidor de mek para el tratamiento de infecciones virales y bacterianas. | |
EA201891508A1 (ru) | Композиции и методы применения новых штаммов lactobacillus fermentum | |
WO2018236086A3 (ko) | 신규한 에로모나스 하이드로필라 박테리오파지 Aer-HYP-2 및 이의 에로모나스 하이드로필라 균 증식 억제 용도 |